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Abstract
Objective: To explore potential predictors of self-reported paretic arm use at baseline and after task-specific training (TST) in survivors of stroke.
Design: Data were obtained from a randomized controlled trial of somatosensory stimulation and upper limb TST in chronic stroke.
Setting: University laboratory.
Participants: Chronic (3mo) survivors of stroke (NZ33; mean age, 62y; mean stroke duration, 38mo).
Interventions: Participants received 12 sessions of TST preceded by either active (nZ16) or sham (nZ17) somatosensory stimulation to all 3
peripheral nerves.
Main Outcome Measures: Demographic and clinical characteristics were entered stepwise into multiple linear regression analyses to determine
the factors that best predict baseline Motor Activity Log (MAL) amount of use rating and change 3 months after TST.
Results: The Action Research Arm Test (ARAT) score predicted the amount of use at baseline (R2Z.47, P<.001); in using this model, an ARAT
score of 54 (maximum of 57) is required to score 2.5 on the MAL (use described as between rarely and sometimes). After TST the change in the
ARAT score predicted the change in the amount of use (R2Z.31, PZ.001). The predictive power of the model for change at 3 months increased if
the Fugl-Meyer Assessment wrist component score was added (R2Z.41, PZ.001).
Conclusions: Utilization of the paretic upper limb in activities of daily living requires high functional ability. The increase in self-reported arm
use after TST is dependent on the change in functional ability. These results provide further guidance for rehabilitation decisions.
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increasing independence in daily activities.1,2 A challenge in
rehabilitation is identifying the main determinants of functional
ability and the potential for recovery. This is of paramount
importance to guide the planning of therapy goals, to manage the
expectations of patients and their cargivers, and for organization
of rehabilitation services. The potential for clinical, neurophysi-
ological, and imaging measures to predict the ability to make
meaningful recovery has recently received considerable interest.3,4
However, for chronic brain injury, the relation between motor
function and amount of paretic arm use is largely unknown.Supported by The Dunhill Medical Trust (grant no. R102/0209) and the South London Clinical
Local Research Network.
Clinical Trial Registration No.: ISRCTN 05542931.
No commercial party having a direct financial interest in the results of the research supporting
this article has conferred or will confer a benefit on the authors or on any organization with which
the authors are associated.
0003-999314 36 ª 2014 by the American Congress of Rehabilitation Medicin
http://dx.doi.org/10.1016/j.apmr.2014.01.009Previous studies examining change in arm use after constraint-
induced movement therapy (CIMT) have found distal arm func-
tion to be a significant factor,5,6 but further investigation of
baseline paretic arm use and change after therapy is needed.
Whether the arm affected by stroke was previously dominant or
nondominant may impact on recovery,7 learned disuse, and the
perseverance of survivors of stroke to reintroduce the paretic arm
into activities of daily living. Recent evidence suggests that
functional ability must be quite high in order for survivors of
stroke to regularly use their affected arm,8,9 and there is a call for
further investigation into this.9
Task-specific training (TST) is a rehabilitation technique that
involves goal-directed practice of motor tasks with the aim of
improving task performance. Patients repeatedly perform func-
tional tasks and are given feedback on their performance.10 TST
has been shown to be effective at improving upper limb functione Open access under CC BY-NC-ND license.
Predicting paretic arm use after stroke 919after stroke and is regularly used by therapists.10-12 Improvements
in self-reported amount of arm use after TST have been demon-
strated,11 but it is unclear what characteristics predict the change
in the amount of paretic arm use after a TST intervention.
The aims of this study were to explore, in survivors of chronic
stroke, the potential predictors of self-reported amount of arm use
(Motor Activity Log [MAL]13) and the potential for increases in
the amount of use after TST. We also aimed to determine whether
predictors of arm use differed between patients whose dominant
and nondominant arms were affected.
Methods
Data for this study were collected during a randomized controlled
trial (RCT) of somatosensory stimulation and upper limb TST in
survivors of chronic stroke. This was approved by the National
Research Ethics Service and registered as an RCT (ISCRTN
05542931). Written informed consent was obtained from each
participant. After baseline assessments, participants were block-
randomized to receive 2 hours of either active or sham somatosen-
sory stimulation followed by 30 minutes of TST, 3 times per week
for 4 weeks. Participants and the assessor (M.K.F.) were blinded to
group allocation, but the treating physiotherapist (S.F.R.L.) was not.
Two baseline assessments were conducted to ensure stability, and
follow-up assessments were conducted immediately after the
intervention and at 3 and 6 months. We report the data from the
baseline assessments and the 3 month follow-up because there were
no differences between groups in any assessment at these time
points, and it was thought that 3 months after TST would give a
better indication of training-related changes in habitual arm use than
immediately after the intervention.
Participants
Participants were recruited for the RCT from local National Health
Service sites, stroke support groups, and word of mouth. Inclusion
criteria were age >18 years, single stroke of 3 months duration,
unilateral upper limb weakness, completed upper limb rehabilitation,
and the presence ofmotor-evoked potentials in response to transcranial
magnetic stimulation with the muscles either at rest or preactivated (to
ensure potential for functional improvement14). Exclusion criteria
were contraindications to transcranial magnetic stimulation (eg, epi-
lepsy or seizures), cardiac pacemakers or metal implants in the head,
severe spasticity (4 on the Modified Ashworth Scale [MAS]15),
wheelchair-bound, or presence of dysphasia or cognitive dysfunction
sufficient to limit the ability to provide informed consent.
Task-specific training
All participants received 12 sessions (4wk) of TST with an
experienced neurophysiotherapist (S.F.R.L.). Each 30-minuteList of abbreviations:
ARAT Action Research Arm Test
CIMT constraint-induced movement therapy
FMA Fugl-Meyer Assessment
MAL Motor Activity Log
MAS Modified Ashworth Scale
RCT randomized controlled trial
TST task-specific training
www.archives-pmr.orgsession was divided into 6 sections of 5 minutes: stretching and
warm-up, grasp, grip, pinch, gross movements, and patient choice.
The tasks were based around those required for the Action Research
Arm Test (ARAT)16 and were practiced in a pseudo-randomized
order in each session.10
Clinical variables (predictors)
Demographic and clinical variables were chosen that are
commonly assessed in survivors of stroke in clinical and/or
research settings and could be logically thought to have a potential
influence on the amount of paretic arm use. Data were obtained
from the assessments of the RCT. These variables included age,
time since stroke (chronicity), Barthel Index,17 MAS,15 baseline
ARAT,18 baseline upper limb Fugl-Meyer Assessment (FMA),19
and change in ARAT and FMA 3 months after TST. The ARAT
and FMA are standardized measures of upper limb func-
tion.16,18,19 The ARAT is formed of 4 subsections: grasp, grip,
pinch, and gross. Each task is scored out of 3 (high score means
good function, maximum of 57). The FMA is formed of 4 sub-
sections: shoulder, wrist, hand, and coordination. Each task is
scored out of 2 (high score means good function, maximum of 66).
The subsection scores were also included as potential predictors.
Outcome measure (dependent variable)
The dependent variables were the average baseline MAL amount
of use and the change 3 months after TST. The MAL requires
participants to report how much (amount of use) they use their
affected arm for a selection of daily activities. Ratings are from
0 (arm not used at all) to 5 (used as much as before the stroke).
Data analysis
After confirmation that the 2 baseline assessments were not
statistically different (paired t tests), mean values were used for
the ARAT, FMA, and MAL. Spearman correlations were per-
formed to determine whether clinical and demographic factors
(table 1) correlated with baseline MAL amount of use rating.
Forward stepwise multiple linear regression analysesa were
conducted to explore the variables that predicted baseline MAL
amount of use and change in the amount of use 3 months after
TST. Because this study was exploratory, all clinical variables
were entered as potential predictors. The criterion for keeping a
variable in the forward stepwise regression was a significant
contribution to the model (P.05). The criterion for removing a
variable was if it was not making a significant contribution to the
model (P0.1). Paired t tests were used to compare the ARAT,
FMA, and MAL scores before and after TST. Significance was set
at alphaZ.05.
Results
Thirty-three patients (13 women; mean age, 61.5y) were included.
Participant characteristics and assessment scores are presented in
table 1. There were no significant differences in function or MAL
scores between those who received active (nZ16) or sham
(nZ17) somatosensory stimulation at baseline or for the changes
3 months after TST (independent samples t test; P>.05); therefore,
all participants were grouped together for the analyses. The mean
Table 1 Participant characteristics and assessment scores
Participant Age (y) Chronicity (mo) BI Affected Arm MAS
Baseline After Physiotherapy
ARAT FMA MAL D ARAT D FMA D MAL
1 82 26 16 D 0 40.5 52.5 2.1 NA NA NA
2 78 17 17 N 0 46.5 58.5 2.1 5.5 3.5 0.3
3 70 46 19 D 3 28.5 34.0 0.5 1.5 2.0 0.2
4 84 126 17 D 3 10.5 25.0 0.0 3.5 2.0 0.1
5 63 26 20 D 1 42.5 60.5 1.5 2.5 1.5 0.7
6 54 18 17 D 3 10.0 24.0 0.6 2.0 1.0 0.2
7 77 57 18 N 2 19.5 33.5 0.4 0.5 3.5 0.6
8 62 76 16 N 1 37.5 42.0 0.7 2.5 2.0 0.3
9 50 60 20 D 0 31.5 57.5 2.4 5.5 1.5 0.7
10 74 3 14 N 0 43.5 51.0 1.4 7.5 8.0 1.4
11 64 89 20 D 1 37.5 42.0 2.9 4.5 5.0 0.0
12 74 53 20 D 1 29.5 52.0 1.8 9.5 5.0 0.7
13 35 14 18 N 3 30.0 43.0 1.7 4.0 4.0 0.7
14 77 37 15 N 3 10.5 22.0 0.4 0.5 0.0 0.1
15 79 18 17 N 2 36.5 33.0 1.4 NA NA NA
16 49 16 16 D 0 29.5 43.0 0.9 7.5 5.0 1.1
17 45 16 19 D 1 37.0 44.5 2.4 2.0 2.5 0.1
18 55 4 20 N 0 48.5 47.0 1.3 2.5 4.0 1.2
19 24 124 20 D 2 11.0 31.0 0.4 5.0 3.0 0.1
20 61 58 17 N 1 37.0 39.0 1.9 3.0 11.0 0.2
21 57 7 17 D 0 38.0 38.0 2.4 3.0 2.0 0.5
22 66 6 20 N 2 35.5 34.0 2.0 4.5 4.0 0.2
23 45 3 18 N 1 35.5 45.0 1.9 9.5 9.0 2.0
24 65 54 19 D 3 9.0 26.5 0.4 1.0 0.5 0.6
25 69 54 20 D 2 10.0 34.0 1.5 NA NA NA
26 59 4 20 N 0 38.0 46.0 1.5 10.0 12.0 0.9
27 54 17 18 D 0 38.5 48.0 2.7 1.5 6.0 1.2
28 60 8 20 D 1 34.5 30.0 1.9 4.5 9.0 1.0
29 64 130 20 D 2 34.5 54.5 1.6 0.5 2.5 1.6
30 56 13 19 D 2 29.0 37.5 1.6 1.0 1.5 0.2
31 36 43 20 N 1 16.0 30.0 1.0 1.0 1.0 0.0
32 66 9 16 D 1 20.0 33.5 0.7 2.0 3.5 0.0
33 74 12 17 N 1 18.0 29.5 0.8 4.0 1.5 0.0
Mean  SD 61.514.2 37.736.7 18.21.8 NA 1.31.1 29.511.9 40.010.5 1.4.8 2.44.0 2.34.5 0.40.7
Minimum 24.0 3.0 14.0 NA 0.0 9.0 22.0 0.0 10.0 12.0 0.9
Maximum 84.0 130.0 20.0 NA 3.0 48.5 60.5 2.9 9.5 11.0 2.0
Abbreviations: BI, Barthel Index; D, change; D, dominant; N, nondominant; NA, not applicable.
920 M.K. Fleming et altime since stroke  SD was 37.736.7 months, baseline ARAT
score was 29.511.9, and FMA score was 40.010.5. All par-
ticipants were right handed prior to stroke, and 19 had their right
arm affected. Three participants failed to attend the 3-month
follow-up assessment; therefore, their data are not included for the
prediction of change in MAL amount of use.
Correlations with the amount of use
The results of the Spearman correlations are presented in table 2.
There was a significant negative correlation between the amount
of use and the MAS (PZ.001), and there were positive correla-
tions with the ARAT and FMA (P<.01) (fig 1).
Predicting baseline amount of use
The baseline ARAT score predicted 47% of the variability in
baseline MAL amount of use (F1,31Z27.457; P<.001). In usingthe equation for the regression model, an ARAT score of 54 is
required to reach an amount of use score of 2.5 (half the maximum
value, described as between rarely and half as much as before the
stroke). All other clinical variables were excluded, not signifi-
cantly adding to the predictive power of the model (all P>.19).
If participants were examined separately based on which hand was
affected, thebaselineARATscore still stronglypredicted the amount of
use for thosewith the dominant hand affected (R2Z0.6; F1,17Z25.518;
P<.001). The equation for this regression model calculates that an
ARAT score of 46 is required for an amount of use score of 2.5.
For participants with the nondominant hand affected, the
ARAT gross component score predicted 56.8% of the variability in
the amount of use (F1,12Z15.806; PZ.002). The equation for the
regression model calculates that patients will not score 2.5 even
if they reach a maximum score on the grasp component of the
ARAT. The predictive power of the model was further increased
when the FMA wrist component score was added (R2Z0.7;
F2,11Z13.069; PZ.001).www.archives-pmr.org
Table 2 Spearman correlations with baseline amount of use
rating (MAL)
Independent Variable R P
Chronicity .274 .123
MAS .565 .001*
Age .137 .446
Barthel Index .275 .122
Baseline ARAT .685 <.001*
Baseline FMA .611 <.001*
ARAT subcomponents
Grasp .670 <.001*
Grip .645 <.001*
Pinch .609 <.001*
Gross .537 <.001*
FMA subcomponents
Shoulder .546 .001*
Wrist .489 .004*
Hand .504 .003*
Coordination .080 .656
Abbreviation: R, correlation coefficient.
* P<.05.
Predicting paretic arm use after stroke 921Predicting change in the amount of use after TST
ARAT, FMA, and MAL scores increased significantly after TST
(P<.01) (see table 1). Changes in the ARAT score predicted 30.8%
of the variability in change in MAL amount of use (F1,28Z12.486;
PZ.001). The relation between change in ARAT score and change
in the amount of use is presented in figure 2. The predictive power
of the model increased to 41.1% when the FMA wrist component
score at baseline was added (F2,27Z9.424; PZ.001). All other
clinical variables were excluded because they did not significantly
add to the predictive power of the model (all P>.11).
For the participants with the dominant hand affected, the
baseline FMA wrist score predicted 30.6% of the variability in
change in the amount of use (F1,15Z6.601; PZ.021). For par-
ticipants with the nondominant hand affected, the change in the
grasp component of the ARAT predicted 58.8% of change in the
amount of use (F1,11Z15.674; PZ.002).
Discussion
This exploratory study describes the relation between functional
ability and self-reported amount of paretic arm use in survivors of
chronic stroke (3mo) at baseline and after 4 weeks of TST.
Although most participants were fairly independent (average
Barthel Index score of 18.2), the paretic arm was reportedly used
for daily activities for less than half of the time. Upper limb
function predicted the amount of use rating at baseline, and the
change in function predicted the change in the amount of use
rating after TST, indicating that good functional ability is neces-
sary to promote upper limb utilization.
Both the ARAT and FMA were found to correlate positively
with the baseline MAL score, confirming previous findings8,20,21;
spasticity (MAS) was negatively correlated with the amount of
use. However, 31 of the 33 participants scored <2.5 on the MAL,
indicating that they use their paretic hand substantially less than
prior to stroke. Participants with an ARAT score 20 or a FMA
score 30 had average MAL scores of 0.6 and 0.7 respectively,
indicating virtually no use of the paretic limb (see fig 1). For thewww.archives-pmr.orgparticipants who scored the maximum of 20 on the Barthel Index
(indicating full independence), the average MAL score was 1.6,
providing further support that global measures lack sensitivity
and, therefore, may be unsuitable to capture the effects of therapy
in clinical trials.9 The regression model indicated that an ARAT
score 54 (out of 57) would be necessary before the amount of
use rating would exceed 2.5 (between rarely and half as much as
before the stroke). This suggests that the functional ability of the
upper limb needs to be almost perfect before patients will begin to
habitually engage the arm in daily activities.
When the dominant hand was affected by stroke, the predictive
power of the ARAT score was higher than when all patients were
grouped together, and theARAT score necessary to achieve anMAL
score of 2.5was reduced to 46. This indicates that survivors of stroke
are more likely to use their affected hand, even in the presence of
more severe paresis, if they habitually used it for most activities
prior to the stroke. This may suggest that learned disuse is easier to
overcome if the dominant hand is affected. However, in patients
whose stroke affected their nondominant hand, the model predicted
that even perfect gross upper limb functionwould not be sufficient to
ensure that they would use their upper limb regularly. If confirmed
by other studies, particularly with objective measures of arm use,
this could have serious implications for therapy decisions.
All of the participants had the potential to achieve meaningful
improvements in function with training14; after 4 weeks of TST,
functional ability and amount of use rating increased significantly.
Change in the ARAT score was found to predict 30.8% of the
change in MAL amount of use, further supporting the idea that
functional improvement is necessary for increased arm use. The
predictive model was strengthened by the inclusion of the baseline
FMAwrist subcomponent score, indicating that the ability to make
movements at the wrist is an important factor for making gains in
arm use after therapy. This is a stronger model than those reported
previously after CIMT5,6 and confirms that prioritizing physical
therapy for survivors of stroke with some degree of distal hand
function could enhance the possibility of making gains in paretic
arm use. This may be particularly so for participants with the
dominant hand affected, in which the baseline FMAwrist score was
found to be the main predictor of change in the amount of use.
Study limitations
This study has explored potential predictors of self-reported
paretic arm use rather than actual arm use. Although the MAL
has been found to be reliable and valid,13 it is a subjective measure
rather than an objective one. One advantage of a self-report
measure over those from other devices (eg, accelerometers) in-
cludes the ability to capture the stroke survivor’s perspective of
how his or her arm use has changed. Even if not truly reflective of
actual arm use, his or her opinion is important. However, results
could be affected by a participant’s desire to please the investi-
gator or poor recall of actual use. The perspective of the survivor
of stroke is increasingly considered as an important way to
measure the impact of stroke and outcomes after rehabilitation.
One limitation is that all participants were in the chronic phase
of stroke recovery (range, 3e130mo) and had completed and been
discharged from standard upper limb rehabilitation. It remains to
be determined whether the predictors of change in MAL score will
be the same in the early period after brain injury when more
spontaneous recovery will occur. Interestingly, time since stroke
did not correlate with the baseline MAL score or predict either the
baseline MAL score or change after TST. In addition, the
Fig 1 Scatterplot showing the relation between the ARAT score (A), FMA score (B), and MAL amount of use rating at baseline.
922 M.K. Fleming et alregression model explains a small-to-moderate proportion of the
variance in self-reported arm use; therefore, there are other
possible factors that may determine a patient’s perception of his or
her arm use. It is important to continue to investigate other
possible determinants to help guide rehabilitation goals. These
could include aspects such as living situation, cognitive status,
work, or other activity requirements. These aspects were notassessed as part of this study but could potentially contribute
significantly. One of the strengths of this study is that patients had
a range of ages and stroke durations; neither of these factors
appeared to influence the amount of use or the potential to in-
crease the amount of use with TST. However, this is in contrast
with Lin,6 Fritz,22 and colleagues, who reported age to be a pre-
dictor of change in the amount of use after CIMT. The differenceswww.archives-pmr.org
Fig 2 Scatterplot showing the relation between the change in the ARAT score and the change in the MAL amount of use rating after TST.
Predicting paretic arm use after stroke 923may lie in the types of therapy delivered. CIMT is an intense
rehabilitation regimen requiring restraint of the unaffected upper
limb and making it essential for patients to use their paretic arm
for activities. In contrast, TST (as used in the present study)
involved less intense retraining of the paretic limb without spe-
cifically inhibiting use of the less affected arm. It is conceivable
that age may affect the response to the 2 therapy interventions
differently, and this could impact on behavioral change, which has
clinical implications for therapeutic provision.
Conclusions
There is a substantial amount of research underway to attempt to
predict the chance of recovery of arm function after stroke. These
results provide further information to guide rehabilitation de-
cisions, providing support for the idea that high functional ability
is important for survivors of stroke to report adequate use of the
upper limb in activities of daily living.
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